innovator drugs Archives

2 July 2025

Malaysia

Drug Procurement Maelstrom In MOH Triggers Industry Discontent

Confusion reigns about drug procurement in MOH, with issues like delays in procuring medicines, risking shortages; choosing generics at 100% to 200% higher prices than off-patent innovators; “opaque” tenders and insufficient support for the local industry.

16 May 2025

Malaysia

IJN Shifts To Mainly Generics, But Still Prescribes Some Innovators

IJN CEO Prof Ezani says IJN has shifted to mostly generics, but still provides some new innovator drugs due to existing contracts and the need to uphold IJN's reputation as a top cardiovascular hospital. Government referrals to IJN have dropped “slightly”.

12 November 2024

Malaysia

Minister Confirms IJN To Switch To Generic Drugs

Dr Dzul says IJN has agreed to switch from innovators to generics. The health minister hopes this will generate "large savings" for the government. IJN's prices for its 10 most prescribed drugs charged to MOH are up to 4,300% higher than MOH procurement.

8 November 2024

Letter

Clarification Of Statement On IJN’s Switch To Generic Medicines — PhAMA

PhAMA says its earlier statement on IJN's switch to generics erroneously implied that this may compromise patient safety. PhAMA clarifies it was referencing IJN's critically ill patients, saying a sudden change may not be advisable without clinical reason.

6 November 2024

Malaysia

Switching To Generics And Biosimilars Will Ensure IJN’s Sustainability: MOPI

MOPI says shifting to generics and biosimilars, which are widely used in developed countries, will ensure IJN's sustainability. “Generics and biosimilars are not ‘cheap alternatives’ – they are therapeutically equivalent to their originator counterparts.”

1 November 2024

Malaysia

MMA Urges Patient Education In IJN’s Mandated Switch To Generics

MMA calls for patient education and obtaining the best quality generic medicines, after the government directed IJN to switch its public patients to generics. In cases where generic versions aren't available, MMA says originator drugs must still be given.

Tag: innovator drugs

Drug Procurement Maelstrom In MOH Triggers Industry Discontent

IJN Shifts To Mainly Generics, But Still Prescribes Some Innovators

Minister Confirms IJN To Switch To Generic Drugs

Clarification Of Statement On IJN’s Switch To Generic Medicines — PhAMA

Switching To Generics And Biosimilars Will Ensure IJN’s Sustainability: MOPI

MMA Urges Patient Education In IJN’s Mandated Switch To Generics

Pork Importers Back Pig Farming Ban In Selangor

Time To Phase Out Colonial-Era PTD Scheme From Malaysia’s Civil Service

Sultan Sharafuddin Wants Total Pig Farming Ban In Selangor

Half Of EPF Members Have Under RM50,000, KWAP Warns Of ‘Optimism Bias’

Critical Manpower Shortage, Unsafe Working Conditions At HTAR Klang — Medical Officer